HIV-associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity

International Journal of Biological Markers

Volumn 22, Issue 2, 2007, Pages 161-163

  Carbone, Antonino ^a   Cabras, A ^a   Gloghini, A ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD30 ANTIGEN; CD40 LIGAND; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL SURVIVAL; DISEASE ASSOCIATION; EOSINOPHIL; EPSTEIN BARR VIRUS; FIBROBLAST; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOCYTE; LYMPHOCYTE DEPLETION; MACROPHAGE; PATHOGENESIS; PLASMA CELL; REED STERNBERG CELL; REGULATORY T LYMPHOCYTE; STROMA CELL; TUMOR ESCAPE;

EID: 34447303051     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.714     Document Type: Letter

References (15)

1. Schwering I, Bräuninger A, Klein U, et al. Loss of the Blineage-specific gene expression program in Hodgkin's and Reed-Sternberg cells of Hodgkin's lymphoma. Blood 2003; 101: 1505-12.
2. Kanzler H, Küppers R, Hansmann ML, Rajewsky K. Hodgkin's and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495-505.
3. Bräuninger A, Schmitz R, Bechtel D, Renne C, Hansmann ML, Küppers R. Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 2006; 118: 1853-61.
4. Re D, Küppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005; 23: 6379-86.
5. Carbone A, Gloghini A, Gattei V, et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780-9.
6. Carbone A, Gloghini A, Gruss H-J, Pinto A. CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147: 912-22.
7. Gires O, Zimber-Strobl U, Gonnella R, et al. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997; 16: 6131-40.
8. Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192: 303-10.
9. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001; 167: 1137-40.
10. Apoil PA, Puissant B, Roubinet F, Abbal M, Massip P, Blancher A. FOXP3 mRNA levels are decreased in, peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 2005; 39: 381-5.
11. Alvaro T, Lejeune M, Salvado MT, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11: 1467-73.
12. Carbone A, Gloghini A, Larocca LM, et al. HIV-associated Hodgkin's disease derives from post-germinal center B-cells. Blood 1999; 93: 2319-26.
13. Herida A, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447-53.
14. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-32.
15. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20: 1645-54.